These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 11389055

  • 1. Vitamin D receptor gene polymorphisms, insulin-like growth factors, and prostate cancer risk: a population-based case-control study in China.
    Chokkalingam AP, McGlynn KA, Gao YT, Pollak M, Deng J, Sesterhenn IA, Mostofi FK, Fraumeni JF, Hsing AW.
    Cancer Res; 2001 Jun 01; 61(11):4333-6. PubMed ID: 11389055
    [Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factors and prostate cancer: a population-based case-control study in China.
    Chokkalingam AP, Pollak M, Fillmore CM, Gao YT, Stanczyk FZ, Deng J, Sesterhenn IA, Mostofi FK, Fears TR, Madigan MP, Ziegler RG, Fraumeni JF, Hsing AW.
    Cancer Epidemiol Biomarkers Prev; 2001 May 01; 10(5):421-7. PubMed ID: 11352850
    [Abstract] [Full Text] [Related]

  • 3. Prostate cancer risk in relation to selected genetic polymorphisms in insulin-like growth factor-I, insulin-like growth factor binding protein-3, and insulin-like growth factor-I receptor.
    Chen C, Freeman R, Voigt LF, Fitzpatrick A, Plymate SR, Weiss NS.
    Cancer Epidemiol Biomarkers Prev; 2006 Dec 01; 15(12):2461-6. PubMed ID: 17164371
    [Abstract] [Full Text] [Related]

  • 4. Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancer.
    Severi G, Morris HA, MacInnis RJ, English DR, Tilley WD, Hopper JL, Boyle P, Giles GG.
    Cancer Epidemiol Biomarkers Prev; 2006 Jun 01; 15(6):1137-41. PubMed ID: 16775172
    [Abstract] [Full Text] [Related]

  • 5. Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.
    Ma J, Stampfer MJ, Gann PH, Hough HL, Giovannucci E, Kelsey KT, Hennekens CH, Hunter DJ.
    Cancer Epidemiol Biomarkers Prev; 1998 May 01; 7(5):385-90. PubMed ID: 9610787
    [Abstract] [Full Text] [Related]

  • 6. Insulin-like growth factors and breast cancer risk in Chinese women.
    Yu H, Jin F, Shu XO, Li BD, Dai Q, Cheng JR, Berkel HJ, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2002 Aug 01; 11(8):705-12. PubMed ID: 12163322
    [Abstract] [Full Text] [Related]

  • 7. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study.
    Lacey JV, Potischman N, Madigan MP, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Lurain JR, Fillmore CM, Sherman ME, Brinton LA.
    Cancer Epidemiol Biomarkers Prev; 2004 Apr 01; 13(4):607-12. PubMed ID: 15066926
    [Abstract] [Full Text] [Related]

  • 8. Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression.
    Xu Y, Shibata A, McNeal JE, Stamey TA, Feldman D, Peehl DM.
    Cancer Epidemiol Biomarkers Prev; 2003 Jan 01; 12(1):23-7. PubMed ID: 12540499
    [Abstract] [Full Text] [Related]

  • 9. Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men.
    Woodson K, Tangrea JA, Pollak M, Copeland TD, Taylor PR, Virtamo J, Albanes D.
    Cancer Res; 2003 Jul 15; 63(14):3991-4. PubMed ID: 12873996
    [Abstract] [Full Text] [Related]

  • 10. Insulin-like growth factors and risk of benign prostatic hyperplasia.
    Chokkalingam AP, Gao YT, Deng J, Stanczyk FZ, Sesterhenn IA, Mostofi FK, Fraumeni JF, Hsing AW.
    Prostate; 2002 Jul 01; 52(2):98-105. PubMed ID: 12111701
    [Abstract] [Full Text] [Related]

  • 11. Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population.
    Habuchi T, Suzuki T, Sasaki R, Wang L, Sato K, Satoh S, Akao T, Tsuchiya N, Shimoda N, Wada Y, Koizumi A, Chihara J, Ogawa O, Kato T.
    Cancer Res; 2000 Jan 15; 60(2):305-8. PubMed ID: 10667581
    [Abstract] [Full Text] [Related]

  • 12. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer.
    John EM, Schwartz GG, Koo J, Van Den Berg D, Ingles SA.
    Cancer Res; 2005 Jun 15; 65(12):5470-9. PubMed ID: 15958597
    [Abstract] [Full Text] [Related]

  • 13. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk.
    Oh JC, Wu W, Tortolero-Luna G, Broaddus R, Gershenson DM, Burke TW, Schmandt R, Lu KH.
    Cancer Epidemiol Biomarkers Prev; 2004 May 15; 13(5):748-52. PubMed ID: 15159305
    [Abstract] [Full Text] [Related]

  • 14. Prostate carcinoma incidence in relation to prediagnostic circulating levels of insulin-like growth factor I, insulin-like growth factor binding protein 3, and insulin.
    Chen C, Lewis SK, Voigt L, Fitzpatrick A, Plymate SR, Weiss NS.
    Cancer; 2005 Jan 01; 103(1):76-84. PubMed ID: 15540247
    [Abstract] [Full Text] [Related]

  • 15. Serum insulin-like growth factor-I levels and prostatic intraepithelial neoplasia: a clue to the relationship between IGF-I physiology and prostate cancer risk.
    Nam RK, Trachtenberg J, Jewett MA, Toi A, Evans A, Emami M, Narod SA, Pollak M.
    Cancer Epidemiol Biomarkers Prev; 2005 May 01; 14(5):1270-3. PubMed ID: 15894684
    [Abstract] [Full Text] [Related]

  • 16. High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.
    Stattin P, Rinaldi S, Biessy C, Stenman UH, Hallmans G, Kaaks R.
    J Clin Oncol; 2004 Aug 01; 22(15):3104-12. PubMed ID: 15284261
    [Abstract] [Full Text] [Related]

  • 17. Vitamin D receptor genotypes/haplotypes and prostate cancer risk.
    Cicek MS, Liu X, Schumacher FR, Casey G, Witte JS.
    Cancer Epidemiol Biomarkers Prev; 2006 Dec 01; 15(12):2549-52. PubMed ID: 17164384
    [Abstract] [Full Text] [Related]

  • 18. Putative role of serum insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels in the development of prostate cancer in Arab men.
    Kehinde EO, Akanji AO, Mojiminiyi OA, Bashir AA, Daar AS, Varghese R.
    Prostate Cancer Prostatic Dis; 2005 Dec 01; 8(1):84-90. PubMed ID: 15775992
    [Abstract] [Full Text] [Related]

  • 19. The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population.
    Medeiros R, Morais A, Vasconcelos A, Costa S, Pinto D, Oliveira J, Lopes C.
    J Hum Genet; 2002 Dec 01; 47(8):413-8. PubMed ID: 12181642
    [Abstract] [Full Text] [Related]

  • 20. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
    Canzian F, McKay JD, Cleveland RJ, Dossus L, Biessy C, Boillot C, Rinaldi S, Llewellyn M, Chajès V, Clavel-Chapelon F, Téhard B, Chang-Claude J, Linseisen J, Lahmann PH, Pischon T, Trichopoulos D, Trichopoulou A, Zilis D, Palli D, Tumino R, Vineis P, Berrino F, Bueno-de-Mesquita HB, van Gils CH, Peeters PH, Pera G, Barricarte A, Chirlaque MD, Quirós JR, Larrañaga N, Martínez-García C, Allen NE, Key TJ, Bingham SA, Khaw KT, Slimani N, Norat T, Riboli E, Kaaks R.
    Cancer Epidemiol Biomarkers Prev; 2005 Oct 01; 14(10):2316-25. PubMed ID: 16214911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.